Fibromyalgia and vitamin D deficiency
Using dietary strategies to aid with fibromyalgia (FM) management continues to be our principal topic these previous two posts and functions as GREAT background information for this month’s issue: Vitamin D and its role in the management of pain related to FM. Let us have a look!
Vitamin D is also found in foods like eggs, fish, fortified milk, cod liver oil, and much more. The sunlight also helps the body produce vitamin D as few as 10 minutes of vulnerability reported to be sufficient to avoid deficiency. There are many distinct kinds of vitamin D, both of both are significant in people: vitamin D2 (produced by crops) and D3 (produced by individual skin exposed to sun). Foods can be fortified with kind, and nutritional supplements can be found in both kinds (D3 is favored). The principal job of vitamin D is to maintain normal blood levels of phosphorus and calcium. Calcium and vitamin D are usually taken together to enhance bone health and reduce fractures.
Studies have also proven that vitamine D may protect against osteoporosis, higher blood pressure, cancer, and other ailments. “Vintage” vitamin D deficiency ailments contain bone reduction conditions like rickets (in children) and osteomalacia (in adults). Individuals at high risk include the elderly, those that are obese, and people with limited sunlight exposure. People with conditions like cystic fibrosis (endometriosis build-up at the lungs) or inflammatory bowel disease can also be at risk for vitamin D deficiency. With that background info, can vitamine D assist FM patients with chronic pain?
At a February 2014 analysis (journal: Illness 2014, Feb 01;155 (2)261-268), the earliest known randomized, placebo-controlled trial between vitamin D supplementation has been conducted on 30 FM girls with serum D3 degrees under 32ng/mol/L (80nmol/L). Half were assigned to vitamine D replacement or a control group that received a placebo (NOT vitamin D). The 2 classes were re-evaluated again after 24 weeks. The principal hypothesis was that those treated with vitamin D3 could have less pain (as measured on a 0-100 pain scale and many other studies). The analysis found there was a noticeable decrease in pain perception from the FM girls treated with D3.
Even though a bigger scale research was advocated to solidify those findings, the authors conclude, “This economic therapy using a very low side effect profile might well be considered in patients with FMS.” This analysis is crucial, as dosing of vitamin D3 (favored over D2 commonly prescribed) was predicated on lack levels and supplied at 1200 to 2400 IU/day. From the end of 3 weeks, those getting D3 improved from a mean of 20 ng/ml to nearly 50 ng/ml and reported that a 20-point decline in pain on a 0-100 scale. Further, roughly 20-25 months after quitting D3, their degrees fell back to26 ng/ml using a corresponding rise in pain levels (by 30 percent).
WebMD reports like chronic pain gains with D3 replacement. In 2003, they noticed D3 deficiency is high “among all U.S. events, races, and ethnic groups within the last two decades” They add a then-recent analysis found that from 150 chronic pain patients, 93 percent of these had “really low” D3 amounts!